Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors ...

A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, ...

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers ...

Give your cat the gift of a vet-free holiday season by keeping these Christmas tree hazards well out of their reach. The post ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

The Tijuana River has been polluted for decades, but in recent years, south San Diego residents say the smell — and their ...

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...

Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...

Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA® (voxelotor) for the treatment ...